Close the Gap Between EMA Policies and Clinical Trial Design

LONDON - March 15, 2013 - PRLog -- SMi's Paediatric Clinical Trials event will aid attendees to close the gap between EMA policies and clinical trial design. A unique insight into the paediatric market it will focus on regulatory requirements, clinical trial design and formulation development.

Some of the speakers who will be presenting include:

• Bruno Reigner, Senior Clinical Pharmacologist, Roche Pharmaceuticals
• David McIntosh, Medical Director, Novartis Vaccines
• Lisa Moore-Ramdin, Medical Affairs Manager, GlaxoSmithKline Ltd
• Luc De Schaepdrijver, Scientific Director Fellow Toxicology and        Pathology, Johnson & Johnson Pharmaceutical Research and  Development
• Paolo Rossi, Head of Department, Children Hospital Bambino Gesùnda

The conference has created quite a buzz in the industry and is almost now sold out. Attendees will include Roche, Johnson & Johnson Celgene,Merck, Boehringer-Ingelheim and Glaxo SmithKline

For further information on the event contact John Collins at jcollins@smi-online.co.uk